Lifecome Biochemistry Co Ltd - Class A

SZSE:002868 (China)   Class A
Â¥ 16.71 (-1.99%) May 24
At Loss
P/B:
6.81
Market Cap:
Â¥ 2.60B ($ 358.60M)
Enterprise V:
Â¥ 3.45B ($ 476.63M)
Volume:
2.55M
Avg Vol (2M):
3.09M
Volume:
2.55M
At Loss
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Lifecome Biochemistry Co Ltd ( ) from 2017 to May 26 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Lifecome Biochemistry stock (SZSE:002868) PE ratio as of May 26 2024 is 0. More Details

Lifecome Biochemistry Co Ltd (SZSE:002868) PE Ratio (TTM) Chart

To

Lifecome Biochemistry Co Ltd (SZSE:002868) PE Ratio (TTM) Historical Data

Total 1191
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Lifecome Biochemistry PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-26 At Loss 2024-03-18 At Loss
2024-05-24 At Loss 2024-03-15 At Loss
2024-05-23 At Loss 2024-03-14 At Loss
2024-05-22 At Loss 2024-03-13 At Loss
2024-05-21 At Loss 2024-03-12 At Loss
2024-05-20 At Loss 2024-03-11 At Loss
2024-05-17 At Loss 2024-03-08 At Loss
2024-05-16 At Loss 2024-03-07 At Loss
2024-05-15 At Loss 2024-03-06 At Loss
2024-05-14 At Loss 2024-03-05 At Loss
2024-05-13 At Loss 2024-03-04 At Loss
2024-05-10 At Loss 2024-03-01 At Loss
2024-05-09 At Loss 2024-02-29 At Loss
2024-05-08 At Loss 2024-02-28 At Loss
2024-05-07 At Loss 2024-02-27 At Loss
2024-05-06 At Loss 2024-02-26 At Loss
2024-04-30 At Loss 2024-02-23 At Loss
2024-04-29 At Loss 2024-02-22 At Loss
2024-04-26 At Loss 2024-02-21 At Loss
2024-04-25 At Loss 2024-02-20 At Loss
2024-04-24 At Loss 2024-02-19 At Loss
2024-04-23 At Loss 2024-02-08 At Loss
2024-04-22 At Loss 2024-02-07 At Loss
2024-04-19 At Loss 2024-02-06 At Loss
2024-04-18 At Loss 2024-02-05 At Loss
2024-04-17 At Loss 2024-02-02 At Loss
2024-04-16 At Loss 2024-02-01 At Loss
2024-04-15 At Loss 2024-01-31 At Loss
2024-04-12 At Loss 2024-01-30 At Loss
2024-04-11 At Loss 2024-01-29 At Loss
2024-04-10 At Loss 2024-01-26 At Loss
2024-04-09 At Loss 2024-01-25 At Loss
2024-04-08 At Loss 2024-01-24 At Loss
2024-04-03 At Loss 2024-01-23 At Loss
2024-04-02 At Loss 2024-01-22 At Loss
2024-04-01 At Loss 2024-01-19 At Loss
2024-03-29 At Loss 2024-01-18 At Loss
2024-03-28 At Loss 2024-01-17 At Loss
2024-03-27 At Loss 2024-01-16 At Loss
2024-03-26 At Loss 2024-01-15 At Loss
2024-03-25 At Loss 2024-01-12 At Loss
2024-03-22 At Loss 2024-01-11 At Loss
2024-03-21 At Loss 2024-01-10 At Loss
2024-03-20 At Loss 2024-01-09 At Loss
2024-03-19 At Loss 2024-01-08 At Loss

Lifecome Biochemistry Co Ltd (SZSE:002868) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Lifecome Biochemistry Co Ltd is a biopharmaceutical company which is engaged in the microbial pharmacy in China. Its main products include Bacitracin Zinc products (Bacitracin Zinc Premix, Bacitracin Zinc API), Colistin Sulfate products (Colistin Sulfate Premix, Colistin Sulfate API), Probiotics products (Bacillus Subtilis, Bacillus Licheniformis), Bacitracin Methylene Disalicylate products, biological preservatives: and Natamycin products.